Acute and mid-term outcomes of transcatheter pulmonary valve implantation in patients older than 40 years

Aldoss, Osamah; Carr, Kaitlin; Shahanavaz, Shabana; Balzer, David T.; Levi, Daniel S.; Aboulhosn, Jamil

doi:10.1016/j.ijcchd.2021.100084

Cited by 2 publications

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The finding of only one recorded transcatheter intervention in the setting of IE is somewhat surprising given that conduit stenosis is frequently implicated in IE. 10,13,27,28 It is conceivable that our methodology of data abstraction did not capture all catheter-based interventions. Alternatively, there may indeed be some overall reluctance to proceed with catheter interventions in the setting of an infected conduit (despite presence of hemodynamic significant right ventricular outflow tract obstruction) with the potential for further embolization of infected materials into the lung.…”

Section: Commentmentioning

confidence: 99%

Outcomes of Treatment for Infective Endocarditis Following Transcatheter Pulmonary Valve Replacement

Fox

Carvajal

Wan

et al. 2023

World J Pediatr Congenit Heart Surg

View full text Add to dashboard Cite

Background Recipients of transcatheter pulmonary valve replacement (TPVR) have shown increased risk of infective endocarditis (IE). Little is known about the outcomes of different management strategies, particularly surgery, for IE after TPVR. Methods We queried the Pediatric Health Information System database for cases of IE after TPVR performed from 2010-2020. We described patient demographics, hospital courses, admission complications, and treatment outcomes based on therapy offered, surgical or medical only. We compared outcomes of initial therapy. Data are expressed as median or percent. Results Sixty-nine cases of IE were identified, accounting for 98 related hospital admissions; 29% of patients recorded IE-related readmissions. Of those readmitted after initial medical therapy only, 33% had relapse IE. Rates of surgery were 22% during initial admission and 36% overall. Likelihood of surgical intervention increased with each subsequent admission. Renal and respiratory failure were more common in those given initial surgery. Mortality rate was 4.3% overall and 8% in the surgical cohort. Conclusion Initial medical therapy may result in relapses/readmissions and possible delay of surgical therapy, which appears to be most effective for treatment of IE. For those treated only medically, a more aggressive course of therapy may be more likely to prevent relapse. Mortality following surgical therapy for IE after TPVR appears higher than reported for surgical pulmonary valve replacement generally.

show abstract

Section: Commentmentioning

confidence: 99%

Outcomes of Treatment for Infective Endocarditis Following Transcatheter Pulmonary Valve Replacement

Fox

Carvajal

Wan

et al. 2023

World J Pediatr Congenit Heart Surg

View full text Add to dashboard Cite

show abstract

Editor's corner & issue at a glance

Gatzoulis

2021

International Journal of Cardiology Congenital Heart Disease

View full text Add to dashboard Cite

Acute and mid-term outcomes of transcatheter pulmonary valve implantation in patients older than 40 years

Cited by 2 publications

References 24 publications

Outcomes of Treatment for Infective Endocarditis Following Transcatheter Pulmonary Valve Replacement

Outcomes of Treatment for Infective Endocarditis Following Transcatheter Pulmonary Valve Replacement

Editor's corner & issue at a glance

Contact Info

Product

Resources

About

Acute and mid-term outcomes of transcatheter pulmonary valve implantation in patients older than 40 years

Cited by 2 publications

References 24 publications

Outcomes of Treatment for Infective Endocarditis Following Transcatheter Pulmonary Valve Replacement

Outcomes of Treatment for Infective Endocarditis Following Transcatheter Pulmonary Valve Replacement

Editor's corner & issue at a glance

Contact Info

Product

Resources

About

Acute and mid-term outcomes of transcatheter pulmonary valve implantation in patients older than 40 years